<DOC>
	<DOCNO>NCT00310401</DOCNO>
	<brief_summary>The purpose study test effectiveness albuterol versus placebo follow specific aim : ) Treatment brain dead organ donor albuterol reduce pulmonary edema , improve donor oxygenation , increase number lung available transplantation , b ) Developing blood test predict development primary graft dysfunction lung transplant recipient , c ) treat brain dead organ donor albuterol decrease marker primary graft dysfunction lead improve lung transplant recipient outcomes high rate lungs suitable transplantation .</brief_summary>
	<brief_title>The Effect Nebulized Albuterol Donor Oxygenation</brief_title>
	<detailed_description>The donor lung utilization rate United States remain less 15 % , demand donor lung far exceed available supply . The common reason failure utilize donor lung donor hypoxemia and/or pulmonary infiltrates . Since pulmonary edema common , reversible cause hypoxemia infiltrate patient brain injury , strategy treat pulmonary edema organ donor lead improve donor oxygenation high rate donor lung utilization . Inhaled beta-2 agonist increase rate alveolar fluid clearance reduce pulmonary edema animal human lung . In addition , group recently report majority human donor lung reject transplantation measurable pulmonary edema respond beta-2 agonist increase rate alveolar fluid clearance . Based compel scientific evidence , propose test efficacy inhale beta-2 agonist increase rate alveolar fluid clearance reduce pulmonary edema brain dead organ donor follow specific aim : Specific Aim 1 : To test effect aerosolize albuterol donor oxygenation multicenter , randomize , double-blinded , placebo-controlled trial 500 brain dead organ donor manage 2 year period California Transplant Donor Network ( CTDN ) . Hypothesis 1a : Treatment brain dead organ donor aerosolize albuterol improve donor oxygenation increase donor lung utilization rate compare treatment placebo . Hypothesis 1b : Treatment brain dead organ donor aerosolize albuterol reduce severity pulmonary edema procure lung compare treatment placebo . Specific Aim 2 : To develop validate panel biological marker predict diagnose acute lung injury due primary graft dysfunction lung transplant recipient . Hypothesis 2a : A panel plasma biological marker measure brain dead organ donor include marker inflammation , coagulation , endothelial injury lung epithelial injury predict development primary graft dysfunction lung recipient . Hypothesis 2b : Treatment brain dead organ donor inhale beta-2 agonist lead reduction level panel biological marker inflammation , coagulation , endothelial injury , lung epithelial injury associate increase donor lung utilization improve recipient outcome .</detailed_description>
	<mesh_term>Pulmonary Edema</mesh_term>
	<mesh_term>Brain Death</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Brain death Consent lung donation donor research Release coroner medical examiner Exclusion Criteria Age less 14 year</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>brain death</keyword>
	<keyword>organ donor</keyword>
	<keyword>pulmonary edema</keyword>
	<keyword>albuterol</keyword>
	<keyword>hypoxia</keyword>
	<keyword>lung transplantation</keyword>
	<keyword>infiltrates</keyword>
</DOC>